GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about INN information from WHO
Product list
Target
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
---|---|---|---|---|---|---|
Pre-Made Ulenistamab biosimilar, Whole Mab: Anti-PAUF therapeutic antibody |
Ulenistamab |
NA |
PAUF |
Whole mAb |
||
Pre-Made Upanovimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Upanovimab |
NA |
SARS-CoV-2 Spike RBD |
Whole mAb |
||
Pre-Made Vepsitamab biosimilar, Whole mAb, Anti-MUC17;CD3E Antibody: Anti-MUC-17/MUC-3/MUC3;T3E/TCRE/IMD18 therapeutic antibody |
Vepsitamab |
NA |
MUC17,CD3E |
Bispecific scFv-scFv-scFc |
||
Pre-Made Voxalatamab biosimilar, Whole mAb, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody |
Voxalatamab |
NA |
FOLH1,CD3E |
Bispecific Whole mAb |
||
Pre-Made Xeligekimab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody |
Xeligekimab |
NA |
IL17A |
Whole mAb |
||
Pre-Made Zamerovimab biosimilar, Whole Mab: Anti-Rabies Virus Spike Glycoprotein G therapeutic antibody |
Zamerovimab |
NA |
Rabies Virus Spike Glycoprotein G |
Whole mAb |
||
Pre-Made Sulesomab Biosimilar, Radiolabelled Antibody: Anti-Nca-90 (Nonspecific Cross- Reacting Antigens 90Kda Glycoproteins, Granulocyte Cell Antigen) therapeutic antibody |
sulesomab |
NA |
NCA-90 (nonspecific cross- reacting antigens 90kDa glycoproteins, granulocyte cell antigen) |
Radiolabelled antibody |
||
Pre-Made Tabituximab Barzuxetan Biosimilar, Whole Mab Adc, Anti-Fzd10 Antibody: Anti-CD350/FZ-10/Fz10/FzE7/hFz10 therapeutic antibody Drug Conjugate |
tabituximab barzuxetan |
NA |
FZD10 |
Whole mAb ADC |
||
Pre-Made Tagraxofusp biosimilar, Protein drug conjugate: Recombinant therapeutic protein drug conjugate |
tagraxofusp |
NA |
IL3 |
Protein drug conjugate |
||
Pre-Made Taldefgrobep Alfa Biosimilar, Fusion Protein targeting MSTN/GDF-8 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting GDF8/MSLHP |
taldefgrobep alfa |
NA |
MSTN |
Fusion Protein |
||
Pre-Made Talizumab Biosimilar, Whole Mab: Anti-Ighe/IgE therapeutic antibody |
talizumab |
NA |
IGHE |
Whole mAb |
||
Pre-Made Tamrintamab Pamozirine Biosimilar, Whole Mab Adc, Anti-Dpep3 Antibody: Anti-MBD3 therapeutic antibody Drug Conjugate |
tamrintamab pamozirine |
NA |
DPEP3 |
Whole mAb ADC |
||
Pre-Made Tanfanercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting TNF-¦Á receptor |
tanfanercept |
NA |
TNF-¦Á receptor |
Recombinant Protein |
||
Pre-Made Taplitumomab Paptox biosimilar, Fusion Protein, Taplitumomab-Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody s |
taplitumomab paptox |
NA |
CD19 |
Fusion Protein |
||
Pre-Made Tarcocimab Biosimilar, Whole Mab, Anti-Vegfa Antibody: Anti-MVCD1/VEGF/VPF therapeutic antibody |
tarcocimab |
NA |
VEGFA |
Whole mAb |
||
Pre-Made Technetium (99Mtc) Fanolesomab Biosimilar, Radiolabelled Antibody, Anti-Cd15 Antibody: Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1 therapeutic antibody |
technetium (99mTc) fanolesomab |
NA |
CD15 |
Radiolabelled antibody |
||
Pre-Made Technetium (99Mtc) Nofetumomab Merpentan Biosimilar, Radiolabelled Antibody: Anti-MS4A1/CD20 therapeutic antibody |
technetium (99mTc) nofetumomab merpentan |
NA |
MS4A1 |
Radiolabelled antibody |
||
Pre-Made Technetium (99Mtc) Pintumomab Biosimilar, Radiolabelled Antibody: Anti-Human Adenocarcinoma Antigen therapeutic antibody |
technetium (99mTc) pintumomab |
NA |
human adenocarcinoma antigen |
Radiolabelled antibody |
||
Pre-Made Tefibazumab Biosimilar, Whole Mab: Anti-Staphylococcus Aureus Fibrin-Binding Surface Epitope Clumping Factor A (Clfa) therapeutic antibody |
tefibazumab |
NA |
Staphylococcus aureus fibrin-binding surface epitope clumping factor A (ClfA) |
Whole mAb |
||
Pre-Made Telimomab Aritox Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody: Anti-LEU1/T1 therapeutic antibody |
telimomab aritox |
NA |
CD5 |
ADC |
||
Pre-Made Telisotuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Met Antibody: Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody Drug Conjugate |
telisotuzumab vedotin |
NA |
MET |
Whole mAb ADC |
||
Pre-Made Telitacicept Biosimilar, Fusion Protein targeting TNFSF13B fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNF |
telitacicept |
NA |
TNFSF13B |
Fusion Protein |
||
Pre-Made Teneliximab Biosimilar, Whole Mab, Anti-Cd40 Antibody: Anti-Bp50/CDW40/TNFRSF5/p50 therapeutic antibody |
teneliximab |
NA |
CD40 |
Whole mAb |
||
Pre-Made Tengonermin Biosimilar, Fusion Protein targeting ANPEP fused with human TNF (tumor necrosis factor (TNF) superfamily member 2, TNFSF2, TNF-alpha, TNFA): Recombinant therapeutic protein targe |
tengonermin |
NA |
ANPEP |
Fusion Protein |
||
Pre-Made Tisotumab Vedotin Biosimilar, Whole Mab Adc, Anti-F3 Antibody: Anti-CD142/TF/TFA therapeutic antibody Drug Conjugate |
tisotumab vedotin |
NA |
F3 |
Whole mAb ADC |
||
Pre-Made Topsalysin biosimilar, Fusion Protein: Recombinant therapeutic protein targeting proaerolysin fused with hexahistidine |
topsalysin |
NA |
proaerolysin |
Fusion Protein |
||
Pre-Made Toralizumab Biosimilar, Whole Mab, Anti-Cd40Lg Antibody: Anti-CD154/CD40L/HIGM1/IGM/IMD3/T-BAM/TNFSF5/TRAP/gp39/hCD40L therapeutic antibody |
toralizumab |
NA |
CD40LG |
Whole mAb |
||
Pre-Made Torapsel Biosimilar, Fusion Protein targeting SELP fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL |
torapsel |
NA |
SELP |
Fusion Protein |
||
Pre-Made Tositumomab Biosimilar, Radiolabelled Antibody, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
tositumomab |
NA |
MS4A1 |
Radiolabelled antibody |
||
Pre-Made Transferrin Aldifitox Biosimilar, Protein Drug Conjugate: Recombinant Therapeutic Protein Drug Conjugate |
transferrin aldifitox |
NA |
transferrin |
Protein drug conjugate |
||
Pre-Made Trastuzumab Beta Biosimilar, Whole Mab, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody |
trastuzumab beta |
NA |
ERBB2 |
Whole mAb |
||
Pre-Made Trastuzumab Deruxtecan Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody Drug Conjugate |
trastuzumab deruxtecan |
NA |
ERBB2 |
Whole mAb ADC |
||
Pre-Made Trastuzumab Duocarmazine Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody Drug Conjugate |
trastuzumab duocarmazine |
NA |
ERBB2 |
Whole mAb ADC |
||
Pre-Made Trastuzumab Emtansine Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody Drug Conjugate |
trastuzumab emtansine |
NA |
ERBB2 |
Whole mAb ADC |
||
Pre-Made Trebananib Biosimilar, Fusion Protein targeting ANGPT2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AGPT2/ANG2/LMPHM10 |
trebananib |
NA |
ANGPT2 |
Fusion Protein |
||
Pre-Made Tucotuzumab Celmoleukin biosimilar, Fusion Protein, Tucotuzumab-Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 th |
tucotuzumab celmoleukin |
NA |
EPCAM |
Fusion Protein |
||
Pre-Made Tulinercept Biosimilar, Fusion Protein targeting TNF fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F |
tulinercept |
NA |
TNF |
Fusion Protein |
||
Pre-Made Tusamitamab Ravtansine Biosimilar, Whole Mab Adc, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody Drug Conjugate |
tusamitamab ravtansine |
NA |
CEACAM5 |
Whole mAb ADC |
||
Pre-Made Tuvirumab Biosimilar, Whole Mab: Anti-Hbv (Hepatitis B Virus) [Hepatitis B Virus] therapeutic antibody |
tuvirumab |
NA |
HBV (hepatitis B virus) [Hepatitis B virus] |
Whole mAb |
||
Pre-Made Upifitamab Rilsodotin Biosimilar, Whole Mab Adc, Anti-Slc34A2 Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM therapeutic antibody Drug Conjugate |
upifitamab rilsodotin |
NA |
SLC34A2 |
Whole mAb ADC |
||
Pre-Made Urtoxazumab Biosimilar, Whole Mab: Anti-E.Coli Shiga-Like Toxin 2 B Subunit therapeutic antibody |
urtoxazumab |
NA |
E.coli Shiga-like toxin 2 B subunit |
Whole mAb |
||
Pre-Made Vadastuximab Talirine Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody: Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody Drug Conjugate |
vadastuximab talirine |
NA |
CD33 |
Whole mAb ADC |
||
Pre-Made Valanafusp Alfa Biosimilar, Fusion Protein targeting INSR fused with human IDUA (iduronidase, alpha-L-) (1:2): Recombinant therapeutic protein targeting CD220/HHF5 |
valanafusp alfa |
NA |
INSR |
Fusion Protein |
||
Pre-Made Vandortuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Steap1 Antibody: Anti-PRSS24/STEAP therapeutic antibody Drug Conjugate |
vandortuzumab vedotin |
NA |
STEAP1 |
Whole mAb ADC |
||
Pre-Made Vapaliximab Biosimilar, Whole Mab, Anti-Aoc3 Antibody: Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic antibody |
vapaliximab |
NA |
AOC3 |
Whole mAb |
||
Pre-Made Vepalimomab Biosimilar, Whole Mab, Anti-Aoc3 Antibody: Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic antibody |
vepalimomab |
NA |
AOC3 |
Whole mAb |
||
Pre-Made Verpasep Caltespen biosimilar, Fusion Protein: Recombinant therapeutic protein targeting HspE7(Mycobacterium bovis HSP65-HBV E7) fused with chaperonin 2 (HSP65 from Mycobacterium bovis) |
verpasep caltespen |
NA |
HspE7(Mycobacterium bovis HSP65-HBV E7) |
Fusion Protein |
||
Pre-Made Volociximab Biosimilar, Whole Mab, Anti-Itga5 Antibody: Anti-CD49eRA/VLA-5/VLA5A therapeutic antibody |
volociximab |
NA |
ITGA5 |
Whole mAb |
||
Pre-Made Vorsetuzumab Mafodotin Biosimilar, Whole Mab Adc, Anti-CD70/CD27-L Antibody: Anti-CD27LG/LPFS3/TNFSF7/TNLG8A therapeutic antibody Drug Conjugate |
vorsetuzumab mafodotin |
NA |
CD70 |
Whole mAb ADC |
||
Pre-Made Votumumab Biosimilar, Radiolabelled Antibody: Anti-Human Carcinoma Associated Antigen Ctaa16 therapeutic antibody |
votumumab |
NA |
human carcinoma associated antigen CTAA16 |
Radiolabelled antibody |